2012
Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females.
Claus EB, Calvocoressi L, Bondy ML, Wrensch M, Wiemels JL, Schildkraut JM. Exogenous hormone use, reproductive factors, and risk of intracranial meningioma in females. Journal Of Neurosurgery 2012, 118: 649-56. PMID: 23101448, PMCID: PMC3756881, DOI: 10.3171/2012.9.jns12811.Peer-Reviewed Original ResearchMeSH KeywordsAdultAge of OnsetAgedBody Mass IndexBreast FeedingConnecticutContraceptives, OralEstrogen Replacement TherapyFemaleHumansMassachusettsMenarcheMeningeal NeoplasmsMeningiomaMenopauseMiddle AgedMultivariate AnalysisNorth CarolinaOdds RatioParityRegistriesReproductive HistoryRisk AssessmentRisk FactorsSan FranciscoSmokingTexasConceptsBody mass indexMeningioma riskMass indexIntracranial meningiomasExogenous hormone useHormone replacement therapyRisk of meningiomaYears of ageCurrent useResidents of ConnecticutHormone medicationWomen 29Postmenopausal womenPremenopausal womenCurrent smokingFertility medicationsOral contraceptivesHormone useMenstrual factorsSignificant positive associationCigarette smokingReplacement therapyRisk factorsReproductive factorsSignificant elevationPostmenopausal hormone therapy and ductal carcinoma in situ: A population-based case–control study
Calvocoressi L, Stowe MH, Carter D, Claus EB. Postmenopausal hormone therapy and ductal carcinoma in situ: A population-based case–control study. Cancer Epidemiology 2012, 36: 161-168. PMID: 22317899, PMCID: PMC3613248, DOI: 10.1016/j.canep.2012.01.001.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedBreast NeoplasmsCarcinoma in SituCarcinoma, Ductal, BreastCase-Control StudiesEstrogen Replacement TherapyFemaleHumansMiddle AgedOdds RatioConceptsPopulation-based case-control studyCase-control studyHormone therapySitu breast cancerBreast cancerDuctal carcinomaRisk of DCISPostmenopausal hormone therapyFrequency-matched controlsInvasive breast cancerPost-menopausal womenDuration of usePostmenopausal womenIncident casesBreast carcinomaDCISLarger studyCarcinomaCancerImportant covariatesEstrogenTherapyAge intervalsWomenCurrent use
2007
Exogenous hormone use and meningioma risk
Claus EB, Black PM, Bondy ML, Calvocoressi L, Schildkraut JM, Wiemels JL, Wrensch M. Exogenous hormone use and meningioma risk. Cancer 2007, 110: 471-476. PMID: 17580362, DOI: 10.1002/cncr.22783.Peer-Reviewed Original ResearchMeSH KeywordsClinical Trials as TopicContraceptives, Oral, HormonalEstrogen Replacement TherapyHumansMeningeal NeoplasmsMeningiomaRisk FactorsConceptsCase-control studyExogenous hormone useHormone replacement therapyMeningioma riskOral contraceptivesHormone useReplacement therapyHospital-based case-control studyPopulation-based case-control studyRandomized clinical trial dataTumor receptor subtypeRetrospective cohort studyCommon clinical questionsLarge national cohortRisk of meningiomaClinical trial dataEnglish-language literatureCohort studyNational cohortReceptor subtypesClinical questionsIntracranial meningiomasTrial dataFurther evaluationExogenous hormones